0001562180-21-005744.txt : 20210902
0001562180-21-005744.hdr.sgml : 20210902
20210902160750
ACCESSION NUMBER: 0001562180-21-005744
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210831
FILED AS OF DATE: 20210902
DATE AS OF CHANGE: 20210902
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Burke Steven Keith
CENTRAL INDEX KEY: 0001619834
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36352
FILM NUMBER: 211233308
MAIL ADDRESS:
STREET 1: 82 WILLIS ROAD
CITY: SUDBURY
STATE: MA
ZIP: 01776
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Akebia Therapeutics, Inc.
CENTRAL INDEX KEY: 0001517022
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 208756903
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 617-871-2098
MAIL ADDRESS:
STREET 1: 245 FIRST STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2021-08-31
false
0001517022
Akebia Therapeutics, Inc.
AKBA
0001619834
Burke Steven Keith
C/O AKEBIA THERAPEUTICS, INC
245 FIRST STREET
CAMBRIDGE
MA
02142
false
true
false
false
SVP, Chief Medical Officer
Common Stock
2021-08-31
4
S
false
1042.00
2.83
D
171219.00
D
This sale was made automatically by the Issuer to cover tax withholding obligations in connection with the vesting and settlement of one-third of the reporting person's restricted stock units granted on August 30, 2019.
Includes 1,500 shares of the Issuer's common stock purchased on June 30, 2021 under the Issuer's 2014 Amended and Restated Employee Stock Purchase Plan.
/s/ Nicole R. Hadas, attorney-in-fact for Steven K. Burke
2021-09-02